Independent public reference library

Ageing biology, biomarkers, interventions, and research literacy.

Developmental Origins of Ageing Trajectories

Key Takeaways

Ageing trajectories do not necessarily begin in old age. The developmental origins of health and disease framework examines how conditions during prenatal life, infancy, and childhood can shape physiology and later vulnerability to chronic disease. Applied to ageing, the central question is not whether development causes one universal form of accelerated ageing, but whether it changes the path along which particular tissues and systems maintain or lose function across life. [1] [2]

Who This Is Useful For

This page is useful for readers interpreting claims about fetal programming, childhood adversity, birth weight, epigenetic ageing, or the long-term effects of early nutrition. It provides a framework for separating evidence about adult disease risk from evidence about the biological rate of ageing.

What an Ageing Trajectory Can Mean

A trajectory is a pattern of biological state or function measured over time. Development can, in principle, influence several distinct parts of that pattern. A person may enter adulthood with a lower functional reserve but subsequently decline at an average rate; another may begin at a similar level but decline more quickly. Either pattern can bring forward the point at which function crosses a disease or disability threshold, yet only the second demonstrates a faster longitudinal rate of ageing. Longitudinal biomarker studies are therefore more informative about pace than a single measurement made late in life. [3] [4]

Trajectory Feature Possible Developmental Effect Interpretive Limit
Starting level Development produces a lasting difference in organ size, structure, or functional capacity. [5] A lower adult level does not by itself demonstrate faster later decline.
Rate of change An exposed group loses measured function more rapidly with advancing age. [3] Repeated measurements are needed to distinguish slope from a persistent group difference.
Threshold crossing Lower reserve or later stress brings forward the age at which disease becomes detectable. [5] [8] Earlier disease can reflect a lower starting point, faster decline, or both.
Tissue specificity One organ system shows a lasting effect while another measured system does not. [3] [7] No single tissue marker represents whole-organism ageing.

How Development Can Leave a Long-Term Biological Signature

Organ Structure and Functional Reserve

Some tissues complete important stages of cell production and structural organization before birth or early in life. Kidney development is a well-studied example: preterm birth, restricted fetal growth, and low birth weight are associated at the population level with lower nephron endowment and later kidney and blood-pressure risk. This supports a reserve model in which developmental conditions alter the capacity available to meet later physiological demands; it does not imply that birth weight alone determines an individual's renal outcome. [5]

Epigenetic Regulation

Epigenetic marks help regulate which genes are active without changing the DNA sequence. In the Dutch Hunger Winter Families Study, exposure to famine around conception was associated with lower DNA methylation at the imprinted IGF2 locus approximately six decades later. The result provides evidence that a developmental exposure can be associated with a persistent molecular difference, but one locus cannot establish a general mechanism of ageing or show that the change caused later disease. [6]

Metabolic Regulation and Later Context

Developmental plasticity allows physiology to respond to nutritional and hormonal cues. The later consequences may depend on the postnatal environment rather than on the early exposure alone. In a rat model, maternal protein restriction and rapid postnatal growth had different associations with offspring lifespan, showing experimentally that exposure timing and subsequent growth can interact. Such models help test causality under controlled conditions, although their diets, development, and lifespans do not map directly onto human experience. [1] [9]

What Human Studies Show

Natural experiments provide some of the clearest human evidence because exposure was tied to a defined historical event. Among 951 participants in the Dutch Hunger Winter Families Study, prenatal famine exposure was associated at about age 58 with a faster DunedinPACE DNA-methylation measure. The association was strongest among women. Results were smaller for GrimAge and absent for PhenoAge, demonstrating that conclusions depended on which biological-age measure was used. [2]

Other outcomes from famine cohorts do not show a uniform acceleration signal. A study at about age 68 found no association between early-gestation famine exposure and leukocyte telomere length. In a later longitudinal brain-imaging study, exposed and unexposed groups differed in some brain measures, but not in their rates of change from ages 68 to 74. The investigators interpreted this as more consistent with a persistent developmental difference than accelerated brain ageing over that interval. [7] [3]

Evidence also extends beyond prenatal nutrition. DunedinPACE was developed from repeated measurements of organ-system change in a birth cohort, and validation analyses found faster values among young adults with childhood adversity. In a separate twin study of children and adolescents, socioeconomic disadvantage was associated with a faster methylation-derived pace-of-ageing measure. These studies connect early social conditions with ageing-related biomarkers, but residual confounding and the interpretation of methylation algorithms remain important limitations. [4] [10]

Birth Size Is a Marker, Not a Mechanism

Birth weight is frequently used in developmental-origins research because it is widely recorded and captures some aspects of fetal growth. It is not a direct measure of maternal nutrition, organ reserve, or later ageing. Large cohort studies have reported associations between low birth weight and adult cardiovascular outcomes, while other long-running cohorts have reported little or no association with cardiovascular morbidity or mortality. Differences in population, survival, recall, gestational age, later exposures, and statistical adjustment can all affect the estimates. Birth size should therefore be treated as an imperfect indicator rather than a deterministic biological programme. [8] [11]

Evidence Quality and Interpretation

Confidence is moderate that some early-life conditions can leave long-lasting molecular, structural, and physiological differences. This conclusion is supported by prospective cohorts, natural experiments, persistent epigenetic associations, and controlled animal studies. Confidence is lower that these effects represent a single generalized acceleration of human ageing, because results vary by sex, tissue, age at exposure, outcome, and biomarker. [2] [3] [6] [9]

Human studies cannot randomly assign famine, prematurity, or childhood adversity. Even natural experiments can be affected by selective fertility and survival, migration, concurrent stress, socioeconomic conditions, and later-life behavior. Animal experiments strengthen mechanistic inference but may use exposures more extreme than typical human variation. Epigenetic clocks are also constructed from different outcomes, so disagreement among them is evidence that they are not interchangeable measurements of one underlying quantity. [2] [4] [7]

What This Does Not Mean

Practical Interpretation Examples

Summary

Development can shape the biological conditions from which later ageing proceeds. Evidence supports persistent effects on some molecular marks, organ capacities, disease risks, and biological-age measures, but it does not support a single, irreversible programme of accelerated ageing. The most useful interpretation separates starting level from rate of decline, treats results as tissue- and measure-specific, and follows the interaction between early conditions and the rest of the life course. [1] [2] [3]

References

  1. Gluckman, P. D., et al. (2010). "A conceptual framework for the developmental origins of health and disease." Journal of Developmental Origins of Health and Disease. https://pubmed.ncbi.nlm.nih.gov/25142928/
  2. Cheng, M., et al. (2024). "Accelerated biological aging six decades after prenatal famine exposure." Proceedings of the National Academy of Sciences. https://pubmed.ncbi.nlm.nih.gov/38833467/
  3. Boots, A., et al. (2025). "Longitudinal changes in late-life brain health after prenatal exposure to the Dutch famine." NeuroImage. https://pubmed.ncbi.nlm.nih.gov/41046062/
  4. Belsky, D. W., et al. (2022). "DunedinPACE, a DNA methylation biomarker of the pace of aging." eLife. https://pubmed.ncbi.nlm.nih.gov/35029144/
  5. Low Birth Weight and Nephron Number Working Group (2017). "The impact of kidney development on the life course: A consensus document for action." Nephron. https://pubmed.ncbi.nlm.nih.gov/28319949/
  6. Heijmans, B. T., et al. (2008). "Persistent epigenetic differences associated with prenatal exposure to famine in humans." Proceedings of the National Academy of Sciences. https://pubmed.ncbi.nlm.nih.gov/18955703/
  7. de Rooij, S. R., et al. (2015). "Prenatal undernutrition and leukocyte telomere length in late adulthood: the Dutch famine birth cohort study." The American Journal of Clinical Nutrition. https://pubmed.ncbi.nlm.nih.gov/26178721/
  8. Huang, X., et al. (2022). "Birth weight and the risk of cardiovascular outcomes: A report from the large population-based UK Biobank cohort study." Frontiers in Cardiovascular Medicine. https://pubmed.ncbi.nlm.nih.gov/35402571/
  9. Langley-Evans, S. C., & Sculley, D. V. (2006). "The association between birthweight and longevity in the rat is complex and modulated by maternal protein intake during fetal life." FEBS Letters. https://pubmed.ncbi.nlm.nih.gov/16828754/
  10. Raffington, L., et al. (2021). "Socioeconomic disadvantage and the pace of biological aging in children." Pediatrics. https://pubmed.ncbi.nlm.nih.gov/34001641/
  11. Eriksson, M., et al. (2004). "The impact of birth weight on coronary heart disease morbidity and mortality in a birth cohort followed up for 85 years: a population-based study of men born in 1913." Journal of Internal Medicine. https://pubmed.ncbi.nlm.nih.gov/15554948/
Educational Disclaimer

This content is provided for educational purposes only and does not constitute medical advice.